Skip to content

Return on assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
8.1%+2.5pp
Myriad Genetics logo
Myriad GeneticsMYGN
-47.6%-63.6pp
Labcorp Holdings logo
Labcorp HoldingsLH
5.1%+0.9pp
Quest Diagnostics logo
Quest DiagnosticsDGX
6.3%+0.3pp
NeoGenomics logo
NeoGenomicsNEO
-6.7%+4.6pp
Natera, Inc. logo
Natera, Inc.NTRA
-18.1%+7.1pp

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Calculated from Fulgent Genetics, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s return on assets?
Fulgent Genetics, Inc. (FLGT) reported return on assets of -6.2% in Q1 2026.
How has Fulgent Genetics, Inc.'s return on assets changed year-over-year?
Fulgent Genetics, Inc.'s return on assets decreased by 86.6% year-over-year, from -3.3% to -6.2%.
What is the long-term trend for Fulgent Genetics, Inc.'s return on assets?
Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s return on assets has grown at a -38.0% compound annual growth rate (CAGR), from 54.3% to -5%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.